Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …

AHEM Maas, G Rosano, R Cifkova… - European Heart …, 2021 - academic.oup.com
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

Prevention of diseases after menopause

RA Lobo, SR Davis, TJ De Villiers, A Gompel… - …, 2014 - Taylor & Francis
Women may expect to spend more than a third of their lives after menopause. Beginning in
the sixth decade, many chronic diseases will begin to emerge, which will affect both the …

[PDF][PDF] Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

Collaborative Group on Epidemiological Studies of … - The Lancet, 2015 - thelancet.com
Background Half the epidemiological studies with information about menopausal hormone
therapy and ovarian cancer risk remain unpublished, and some retrospective studies could …

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for …

R Rizzoli, JC Stevenson, JM Bauer, LJC van Loon… - Maturitas, 2014 - Elsevier
From 50 years of age, postmenopausal women are at an increased risk of develo**
sarcopenia and osteoporosis as a result of deterioration of musculoskeletal health. Both …

Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy

S Salvatore, RE Nappi, M Parma, R Chionna… - …, 2015 - Taylor & Francis
Objective To investigate the effects of fractional microablative CO2 laser on sexual function
and overall satisfaction with sexual life in postmenopausal women with vulvovaginal atrophy …

Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause

M Gambacciani, M Levancini, M Cervigni - Climacteric, 2015 - Taylor & Francis
Aim To evaluate the effects of the vaginal erbium laser (VEL) in the treatment of
postmenopausal women suffering from genitourinary syndrome of menopause (GSM) …

Laser therapy for the restoration of vaginal function

M Gambacciani, S Palacios - Maturitas, 2017 - Elsevier
Laser therapy has a therapeutic role in various medical conditions and most recently has
gained interest as a non-hormonal treatment for genitourinary syndrome of menopause …

Women's experience of menopause: a systematic review of qualitative evidence

L Hoga, J Rodolpho, B Gonçalves… - JBI Evidence …, 2015 - journals.lww.com
Background Evidence shows than an estimated one billion women have experienced
menopause worldwide. The experience of menopause is influenced by beliefs and values …

[HTML][HTML] Management of genitourinary syndrome of menopause in breast cancer survivors: An update

DML López - World journal of clinical oncology, 2022 - ncbi.nlm.nih.gov
There is increasing attention about managing the adverse effects of adjuvant therapy
(Chemotherapy and anti-estrogen treatment) for breast cancer survivors (BCSs) …

Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research

J Grigg, R Worsley, C Thew, C Gurvich, N Thomas… - …, 2017 - Springer
Rationale Hyperprolactinemia is a highly prevalent adverse effect of many antipsychotic
agents, with potentially serious health consequences. Several guidelines have been …